Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00680381 · ClinicalTrials.gov registry record · Phase 1
Transitional Treatment of Adolescents in Family Therapy
A Phase 1 study, sponsored by Oregon Research Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 90
- Enrollment target
NCT00680381 is a Phase 1 study that has completed, run by Oregon Research Institute. The registered enrollment target is 90 participants.
The verdict
NCT00680381, a Phase 1 study, has completed, sponsored by Oregon Research Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 90 participants
- Enrollment target
Study Summary
The purpose of this study is to test different treatments to reduce relapse for drug-abusing adolescents who have completed family therapy. Adolescents receive 12 weeks of family therapy, designed to strengthen family relationships and develop skills for helping the adolescent avoid drug use. Then they are randomly assigned to receive one of three eight-week follow-up treatments: phone calls from a project therapist, group therapy, or a customized schedule of therapist visits with the adolescent, the adolescent's family and teachers, coaches, probation officers and others who can help the adolescent reach or maintain abstinence. Families are assessed using questionnaires and interviews before, during and after treatment, to provide information about family functioning, the adolescent's drug use, the adolescent's peers and other factors that may contribute to treatment success or failure. Adolescents also provide urine specimens for drug screening at assessment visits. Study investigators expect the study will show that a functional family environment and insulating adolescents from the influence of peers who use drugs will help prevent relapse for adolescents who have received family therapy.
Interventions
- BEHAVIORAL MTI, Minimal Transitional Intervention
- BEHAVIORAL GTI, Group Transitional Intervention
- BEHAVIORAL STI, Systems Transitions Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2004-01 |
| Est. Completion | 2014-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00680381
The ClinicalTrials.gov registry entry for NCT00680381 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Research Institute, which has 62 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which MTI, Minimal Transitional Intervention is the first listed.
NCT00680381 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00680381 about?
NCT00680381 is a clinical study titled "Transitional Treatment of Adolescents in Family Therapy". The purpose of this study is to test different treatments to reduce relapse for drug-abusing adolescents who have completed family therapy. Adolescents receive 12 weeks of family therapy, designed to strengthen family relationships and develop skills for helping the adolescent avoid drug use. Then t...
What is the current status of trial NCT00680381?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 90 participants. The study started on 2004-01. Estimated completion is 2014-07.
What interventions are being tested in trial NCT00680381?
The interventions under investigation include: MTI, Minimal Transitional Intervention (BEHAVIORAL), GTI, Group Transitional Intervention (BEHAVIORAL), STI, Systems Transitions Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00680381?
This trial is sponsored by Oregon Research Institute, which has 62 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.